AD-2102
- Generic Name
- AD-2102
Evaluating the Pharmacokinetic Interaction Between AD-2101 and AD-2102
Phase 1
Completed
- Conditions
- Hypertension
- Interventions
- First Posted Date
- 2020-10-23
- Last Posted Date
- 2021-07-21
- Lead Sponsor
- Addpharma Inc.
- Target Recruit Count
- 25
- Registration Number
- NCT04600284
- Locations
- 🇰🇷
Korea University Guro Hospital, Seoul, Korea, Republic of
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath